Editorial: Insights into targeting nanomaterials for drug delivery - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Editorial: Advances in Targeted Nanomaterial-Based Drug Delivery

  • By

  • Mandeep Kaur Marwah

  • November 20, 2026

Share

  • 1

    The Special Issue’s six articles examine targeted nanomaterial delivery, including carrier design, cell- and organelle-specific targeting, formulation, stability, biocompatibility, and toxicity.

  • 2

    Reviews discuss mesoporous silica for mitochondrial delivery and carbon quantum dots, whose biological behavior depends strongly on precursor selection and synthesis-dependent surface chemistry.

  • 3

    In SYLOID, octreotide loading reached 71% recovery, whereas albumin reached a maximum of 32% and remained predominantly on the particle surface.

  • 4

    Cefdinir solid-dispersion and co-amorphous formulations dissolved faster but lost about 50% of drug content during accelerated humid storage; silica retained more than 95%.

  • 5

    The editorial identifies trade-offs in carrier performance and notes that the original investigations were in vitro, with further translational studies needed.

Original Source(s)

Related Content